middle.news

Careteq takes R&D tax dispute to independent review

4:30pm on Friday 20th of November, 2026 AEDT • Healthcare Technology
Read Story

Careteq takes R&D tax dispute to independent review

4:30pm on Friday 20th of November, 2026 AEDT
Key Points
  • ATO rejects objections to amended assessments for FY2021, FY2022 and FY2023
  • Careteq disputes the decision and maintains its R&D activities were eligible
  • Company plans to apply to the Administrative Review Tribunal within weeks
  • Financial exposure and timing of a resolution remain undisclosed
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Careteq (ASX:CTQ)
OPEN ARTICLE